Belharra is so proud to have one of our own, Mike Lazear, be named as one of the Rising Stars in Proteomics and Metabolomics by JPR. This list recognizes emerging scientists in the fields of proteomics and metabolomics selected by the Associate Editors of the Journal of Proteome Research (JPR) and the Editorial Advisory Board members.
BioSpace came up with a list of life science startup companies to watch in 2024 that launched with Series A funding between September 2022 and September 2023 and Belharra is so proud to be a part of this exciting list!
We were so honored to have our CEO Jeff Jonker be a guest on The Long Run with Luke Timmerman, a biotech podcast that focuses on innovations and emerging trends for anyone seeking to understand new drug development diagnostics, genomics, and other technologies that are changing medicine. Jeff spoke with Luke in a podcast titled “The Small Molecule Drug Discovery Renaissance.”
C&EN came up with a list of 10 chemistry start-ups to watch in 2024 based on reader submissions and reporters who talked to chemists and entrepreneurs. We’re so proud to be among this impressive list!